Karl Herrup, Michelle Jin, and James Noble share their perspectives on evaluating the clinical impacts of emerging treatments for Alzheimer’s Disease. Attendees can submit questions at registration and live during the webinar.
Hui Liu 2,3 Zhanfei Yang 2,3 Yuxuan Chen 2,3 Fei Yang 2,3 Xue Cao 2,3 Gao Zhou 2,3 Yu Zhang 1,2,3 * † 1 Department…
How has neurosurgery evolved with new technology? In this clip, Karl Pribram, MD, discusses the progression from early EEGs to modern MR and PET scanning…
An abstract is unavailable.
Functional neurologic disorder is common and a significant cause of disability and stress in neurologic patients. The nature of this disorder has been unclear. Originally…
We speak with neuromuscular disease expert David Lynch, MD, PhD, attending neurologist in the Division of Neurology at Children’s Hospital of Philadelphia and director of…
ed electroconvulsive therapy (MECT). Methods This study recruited 82 SCZ patients and 86 healthy controls (HCs). Each SCZ patient received 6 sessions of MECT. The…
1 Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China 2 Divisio n of Statistics and Data Science, Department of…
Anti-IgLON5 disease is a recently described disorder characterized by autoinflammation targeted against neural cell adhesion proteins (IgLON5) and by tau-mediated neurodegeneration primarily affecting the brainstem…
The rule updates regulations on the reimbursement of physicians under the Medicare program and highlights the need for congressional action on certain issues.
Eye Movements Contribute to Foveal Crowding Ashley Michelle Clark, Aaron Huynh, and Martina Poletti (see article e0594242024) When there are many objects in our surrounding…
